BMI categories (kg/m2) | HR (95% CI), p value Women | HR* (95% CI), p value Men | p Value for sex interaction* | |
All-cause mortality | <18.5 | 1.78 (0.91 to 3.49), 0.09 | 1.72 (0.99 to 2.99), 0.06 | 0.83 |
18.5–24.9 | 1.0 | 1.0 | ||
25.0–29.9 | 0.84 (0.66 to 1.06), 0.14 | 0.97 (0.84 to 1.11), 0.65 | 0.20 | |
⩾30.0 | 1.53 (1.11 to 2.12), 0.01 | 1.22 (0.92 to 1.61), 0.17 | 0.41 | |
CVD mortality | <18.5 | 0.97 (0.24 to 3.95), 0.09 | 0.26 (0.04 to 1.86), 0.18 | 0.34 |
18.5–24.9 | 1.0 | 1.0 | ||
25.0–29.9 | 0.91 (0.64 to 1.31), 0.63 | 1.02 (0.84 to 1.25), 0.82 | 0.58 | |
⩾30.0 | 2.23 (1.42 to 3.49), <0.001 | 1.32 (0.90 to 1.94), 0.16 | 0.15 | |
CHD mortality | <18.5 | 0.0 | 0.40 (0.06 to 2.86), 0.36 | 0.97 |
18.5–24.9 | 1.0 | 1.0 | ||
25.0–29.9 | 1.13 (0.69 to 1.86), 0.63 | 1.07 (0.83 to 1.37), 0.61 | 0.94 | |
⩾30.0 | 1.90 (0.97 to 3.74), 0.06 | 1.59 (1.02 to 2.49), 0.04 | 0.85 | |
Stroke mortality | <18.5 | 0.0 | 0.0 | – |
18.5–24.9 | 1.0 | 1.0 | ||
25.0–29.9 | 0.72 (0.36 to 1.42), 0.34 | 0.97 (0.60 to 1.55), 0.90 | 0.53 | |
⩾30.0 | 2.42 (1.12 to 5.24), 0.02 | 1.02 (0.36 to 2.88), 0.97 | 0.21 | |
Cancer mortality | <18.5 | 2.60 (0.94 to 7.19), 0.07 | 3.05 (1.33 to 6.96), 0.008 | 0.72 |
18.5–24.9 | 1.0 | 1.0 | ||
25.0–29.9 | 0.72 (0.45 to 1.14), 0.15 | 0.93 (0.71 to 1.23), 0.62 | 0.24 | |
⩾30.0 | 1.19 (0.64 to 2.22), 0.58 | 1.18 (0.67 to 2.06), 0.57 | 0.99 | |
Respiratory mortality | <18.5 | 7.14 (0.86 to 58.9), 0.07 | 5.16 (1.84 to 14.5), 0.002 | 0.40 |
18.5–24.9 | 1.0 | 1.0 | ||
25.0–29.9 | 0.67 (0.17 to 2.60), 0.56 | 1.12 (0.76 to 1.64), 0.57 | 0.32 | |
⩾30.0 | 1.74 (0.36 to 8.38), 0.49 | 0.71 (0.25 to 1.97), 0.51 | 0.59 |
*p Values are for separate BMI categories in order to assess sex interactions in underweight, overweight and obese participants separately.
CHD, coronary heart disease; CVD, cardiovascular disease.